Table 4.
Multivariate linear regression analysis showing the sex hormonal factors determining bone marrow adipose tissue in overweight and obese PCOS patients.
| Unadjusted | MV adjusteda | MV adjustedb | ||||
|---|---|---|---|---|---|---|
| β | p | β | p | β | p | |
| FSH | 0.311 | 0.003 | 0.313 | 0.004 | 0.284 | 0.009 |
| LH | 0.098 | 0.369 | 0.098 | 0.372 | 0.131 | 0.234 |
| LH/FSH ratio | -0.067 | 0.536 | -0.068 | 0.534 | -0.027 | 0.808 |
| Estradiol | -0.261 | 0.015 | -0.260 | 0.016 | -0.226 | 0.039 |
| Progesterone | -0.143 | 0.188 | -0.141 | 0.197 | -0.187 | 0.089 |
| TT | 0.138 | 0.203 | 0.135 | 0.217 | 0.124 | 0.262 |
| FT | 0.117 | 0.281 | 0.117 | 0.284 | 0.092 | 0.407 |
| SHBG | -0.133 | 0.220 | -0.136 | 0.215 | -0.102 | 0.354 |
| Prolactin | -0.055 | 0.613 | -0.065 | 0.555 | -0.078 | 0.480 |
aMV model adjusted for age and BMI;
bMV model adjusted for age, BMI, and LDL-C.
FSH, follicle stimulating hormone; LH, luteinizing hormone; LH/FSH, luteinizing hormone/follicle stimulating hormone; TT, total testosterone; FT, free testosterone; SHBG, sex hormone-binding globulin.
The bold values mean statistically significant (p < 0.05).